In AD brains, ac-K311 labeled 3R-tau pathology more robustly than 4R-tau pathology based on prominent colocalization with the 3R-tau specific antibody RD3 (Fig. 3d, compare top row AD–RD3 with AD–RD4). The gene discussed is MAPT; the disease is Alzheimer disease.